Brinter experiences from J.P. Morgan Healthcare, San Francisco
San Francisco is SOLD OUT, and it’s all about Life Science this week!
Brinter Inc’s CEO Tom Alapaattikoski was honored to be presenting at J.P. Morgan Healthcare’s Biotech Showcase.
The first day was a great success for Brinter. We were excited to present our 3D bioprinting tech and application solutions for the pharmaceutical industry, precision oncology, and tissue engineering.
Feedback was very encouraging, as we are fundamentally shifting the global healthcare industry with 3D bioprinting.
We are excited to head into Day 2 with a jam packed calendar!
